S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Semiconductor Giants: Navigating the Recent Pullback
3 Key Stocks Helping to Drive the EV Race
Breakout Alert: Coinbase's Consolidation Is About To End
You Can Follow BlackRock’s Market View for Your Money
Closing prices for crude oil, gold and other commodities
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
How major US stock indexes fared Friday, 4/12/2024
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Semiconductor Giants: Navigating the Recent Pullback
3 Key Stocks Helping to Drive the EV Race
Breakout Alert: Coinbase's Consolidation Is About To End
You Can Follow BlackRock’s Market View for Your Money
Closing prices for crude oil, gold and other commodities
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
How major US stock indexes fared Friday, 4/12/2024
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Semiconductor Giants: Navigating the Recent Pullback
3 Key Stocks Helping to Drive the EV Race
Breakout Alert: Coinbase's Consolidation Is About To End
You Can Follow BlackRock’s Market View for Your Money
Closing prices for crude oil, gold and other commodities
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
How major US stock indexes fared Friday, 4/12/2024
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Semiconductor Giants: Navigating the Recent Pullback
3 Key Stocks Helping to Drive the EV Race
Breakout Alert: Coinbase's Consolidation Is About To End
You Can Follow BlackRock’s Market View for Your Money
Closing prices for crude oil, gold and other commodities
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
How major US stock indexes fared Friday, 4/12/2024

Enovis (ENOV) Stock Price, News & Analysis

$58.57
-1.22 (-2.04%)
(As of 04/12/2024 ET)
Today's Range
$58.11
$59.81
50-Day Range
$58.57
$63.80
52-Week Range
$43.04
$66.14
Volume
342,748 shs
Average Volume
374,716 shs
Market Capitalization
$3.21 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$75.43

Enovis MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
28.8% Upside
$75.43 Price Target
Short Interest
Bearish
8.74% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.64mentions of Enovis in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
18.22%
From $2.58 to $3.05 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.69 out of 5 stars

Medical Sector

221st out of 923 stocks

Surgical Appliances & Supplies Industry

9th out of 17 stocks

ENOV stock logo

About Enovis Stock (NYSE:ENOV)

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

ENOV Stock Price History

ENOV Stock News Headlines

Enovis (NYSE:ENOV) Earns Buy Rating from Needham & Company LLC
Gold Hits New All-Time Highs
Due to both domestic and global issues, the trajectory of this precious metal could skyrocket in the coming months… Which is why billionaires and Central Banks alike are scooping up gold at record rates!
ENOV Dec 2024 60.000 put
Gold Hits New All-Time Highs
Due to both domestic and global issues, the trajectory of this precious metal could skyrocket in the coming months… Which is why billionaires and Central Banks alike are scooping up gold at record rates!
ENOV Mar 2024 60.000 put
ENOV Jun 2024 50.000 put
Q4 2023 Enovis Corp Earnings Call
Enovis Announces Fourth Quarter and Full Year 2023 Results
Enovis Announces Fourth Quarter and Full Year 2023 Results
Enovis Corporation Q4 2023 Earnings Preview
ENOV Mar 2024 70.000 call
5 Analysts Have This To Say About Enovis
See More Headlines
Receive ENOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enovis and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/22/2024
Today
4/12/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Employees
6,550
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$75.43
High Stock Price Target
$82.00
Low Stock Price Target
$70.00
Potential Upside/Downside
+28.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
8 Analysts

Profitability

Net Income
$-33,260,000.00
Pretax Margin
-3.93%

Debt

Sales & Book Value

Annual Sales
$1.71 billion
Cash Flow
$6.25 per share
Book Value
$62.66 per share

Miscellaneous

Free Float
52,043,000
Market Cap
$3.21 billion
Optionable
Optionable
Beta
1.97
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

ENOV Stock Analysis - Frequently Asked Questions

Should I buy or sell Enovis stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Enovis in the last year. There are currently 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ENOV shares.
View ENOV analyst ratings
or view top-rated stocks.

What is Enovis' stock price target for 2024?

8 analysts have issued 12 month target prices for Enovis' shares. Their ENOV share price targets range from $70.00 to $82.00. On average, they predict the company's share price to reach $75.43 in the next year. This suggests a possible upside of 28.8% from the stock's current price.
View analysts price targets for ENOV
or view top-rated stocks among Wall Street analysts.

How have ENOV shares performed in 2024?

Enovis' stock was trading at $56.02 at the beginning of 2024. Since then, ENOV stock has increased by 4.6% and is now trading at $58.57.
View the best growth stocks for 2024 here
.

When is Enovis' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our ENOV earnings forecast
.

How were Enovis' earnings last quarter?

Enovis Co. (NYSE:ENOV) issued its quarterly earnings results on Thursday, February, 22nd. The company reported $0.79 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.76 by $0.03. The company earned $455 million during the quarter, compared to analyst estimates of $444.34 million. Enovis had a positive trailing twelve-month return on equity of 3.84% and a negative net margin of 1.95%. The firm's quarterly revenue was up 11.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.72 earnings per share.

What ETFs hold Enovis' stock?
What guidance has Enovis issued on next quarter's earnings?

Enovis issued an update on its FY24 earnings guidance on Thursday, February, 22nd. The company provided earnings per share (EPS) guidance of $2.50-$2.65 for the period, compared to the consensus EPS estimate of $2.70. The company issued revenue guidance of $2.05-$2.15 billion, compared to the consensus revenue estimate of $2.02 billion.

Who are Enovis' major shareholders?

Enovis' stock is owned by a number of retail and institutional investors. Top institutional shareholders include GAMMA Investing LLC (0.00%). Insiders that own company stock include A Clayton Perfall, Bradley J Tandy, Brady Shirley, Christopher M Hix, Daniel A Pryor, John Kleckner, Matthew L Trerotola, Patricia A Lang, Phillip Benjamin (Ben) Berry and Rajiv Vinnakota.
View institutional ownership trends
.

How do I buy shares of Enovis?

Shares of ENOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:ENOV) was last updated on 4/13/2024 by MarketBeat.com Staff

From Our Partners